Hot Heal Care Stocks To Buy For 2019

PCM (NASDAQ: PCMI) and Insight Enterprises (NASDAQ:NSIT) are both small-cap consumer discretionary companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, valuation, risk and dividends.


Get PCM alerts:

This table compares PCM and Insight Enterprises’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
PCM 0.08% 11.19% 2.09%
Insight Enterprises 1.57% 15.75% 4.89%

Institutional and Insider Ownership

55.2% of PCM shares are owned by institutional investors. Comparatively, 97.1% of Insight Enterprises shares are owned by institutional investors. 24.0% of PCM shares are owned by insiders. Comparatively, 1.8% of Insight Enterprises shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Hot Heal Care Stocks To Buy For 2019: Stryker Corporation(SYK)

Advisors’ Opinion:

  • [By Logan Wallace]

    COPYRIGHT VIOLATION NOTICE: “Stryker Co. (SYK) Holdings Lifted by Daiwa Securities Group Inc.” was posted by Ticker Report and is owned by of Ticker Report. If you are viewing this article on another site, it was copied illegally and republished in violation of US & international trademark and copyright law. The correct version of this article can be viewed at

  • [By Dan Caplinger]

    Finally, shares of Boston Scientific sank 6%. The medical device maker had jumped earlier in the week on reports that it might receive a takeover bid from industry peer Stryker (NYSE:SYK). Yet today, Stryker denied that it had been in acquisition talks with Boston Scientific, throwing cold water on the idea. With the downward push, Boston Scientific is now back to where the stock started the week before the reports surfaced in the first place. Boston Scientific will now apparently have to make the most of its own opportunities in the medical device space — at least unless another potential buyer comes around.

  • [By Logan Wallace]

    US Bancorp DE grew its stake in Stryker Co. (NYSE:SYK) by 2.4% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 154,942 shares of the medical technology company’s stock after purchasing an additional 3,643 shares during the quarter. US Bancorp DE’s holdings in Stryker were worth $24,935,000 at the end of the most recent quarter.

  • [By Ethan Ryder]

    Stryker (NYSE:SYK) had its hold rating reissued by analysts at Needham & Company LLC. The analysts wrote, “SYK is acquiring Invuity (IVTY) for $7.40 per share (a 29% premium) or ~$190M of cash which is 3.4x consensus 2019E sales (vs. 6.4x EV/2019E sales for its medical supplies peers). IVTY makes disposable lighted instruments which increase visibility during minimally invasive surgical (MIS) procedures. We believe IVTY fits well with SYK’s Instruments business and note that IVTY’s products are applicable to a large number of surgical procedures. While the deal may be slightly dilutive in 2019, we believe that SYK can absorb this and still deliver on its 9%+ EPS growth target. And the deal should start to become increasingly accretive in 2020 and beyond.””

  • [By Steve Symington]

    Boston Scientific stock rose 7.4% today after The Wall Street Journal reported (subscription required) that the medical device specialist has received a takeover bid from rival Stryker Corporation (NYSE:SYK). Shares of Stryker simultaneously declined more than 5% on the news.

Hot Heal Care Stocks To Buy For 2019: Treehouse Foods, Inc.(THS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on TreeHouse Foods (THS)

    For more information about research offerings from Zacks Investment Research, visit

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on TreeHouse Foods (THS)

    For more information about research offerings from Zacks Investment Research, visit

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 73.3 percent to $3.90.
    Integrated Media Technology Limited (NASDAQ: IMTE) shares gained 51 percent to $33.1365. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
    Monaker Group, Inc. (NASDAQ: MKGI) shares jumped 34 percent to $3.00.
    Sharing Economy International Inc. (NASDAQ: SEII) shares rose 28.2 percent to $4.51 after gaining 9.32 percent on Wednesday.
    STAAR Surgical Company (NASDAQ: STAA) shares jumped 27.8 percent to $21.40 after reporting upbeat Q1 results.
    Boxlight Corporation (NASDAQ: BOXL) rose 20.5 percent to $8.920 after climbing 107.87 percent on Wednesday.
    Xspand Products Lab Inc (NASDAQ: XSPL) gained 19.5 percent to $ 5.97. Xspand Products priced its IPO at $5 per share.
    YRC Worldwide Inc. (NASDAQ: YRCW) rose 18.9 percent to $10.035 following upbeat quarterly earnings.
    ENDRA Life Sciences Inc. (NASDAQ: NDRA) gained 18.3 percent to $3.0177. ENDRA Life Sciences is expected to report Q1 results on May 15.
    MYR Group Inc. (NASDAQ: MYRG) rose 18.1 percent to $35.85 after the company posted strong Q1 earnings.
    Rudolph Technologies, Inc. (NASDAQ: RTEC) shares jumped 16 percent to $30.75 following upbeat quarterly earnings.
    TTM Technologies, Inc. (NASDAQ: TTMI) gained 13.7 percent to $16.53 after reporting Q1 results.
    Insight Enterprises, Inc. (NASDAQ: NSIT) shares surged 12 percent to $40.06 following better-than-expected Q1 earnings.
    TreeHouse Foods, Inc. (NYSE: THS) rose 11.8 percent to $40.93 following Q1 results.
    Engility Holdings, Inc. (NYSE: EGL) surged 11.2 percent to $27.36. Engility reported upbeat quarterly earnings.
    Synalloy Corporation (NASDAQ: SYNL) rose 10.7 percent to $19.10 following Q1 results.
    Logitech International S.A. (NASDAQ: LOGI)
  • [By Joseph Griffin]

    TechShares (THS) is a distributed proof-of-stake (dPOS) coin that uses the DPoS hashing algorithm. It was first traded on May 28th, 2016. TechShares’ total supply is 646,359,158 coins. The official website for TechShares is

Hot Heal Care Stocks To Buy For 2019: Merck & Company, Inc.(MRK)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Merck & Co. Inc. (NYSE: MRK) and Pfizer Inc. (NYSE: PFE) were named in an August 3 Merrill Lynch report in which the firm rebalanced its income portfolio. It increased its portfolio position in Merck to 3.0% from 2.0% and in Pfizer to 3.0% from 2.5%. AbbVie Inc. (NYSE: ABBV) and Amgen Inc. (NASDAQ: AMGN) were also kept in the portfolio, with weights of 1.5% and 2.0%, respectively.

  • [By Chris Lange]

    Merck & Co. Inc. (NYSE: MRK) has a PDUFA target action date of October 6, for its Gardasil 9 (human papillomavirus 9-valent vaccine, recombinant), the company’s 9-valent HPV vaccine. The application is seeking approval for an expanded age indication for Gardasil 9 for use in women and men ages 27 to 45 for the prevention of certain cancers and diseases caused by the nine HPV types covered by the vaccine.

  • [By ]

    1. Merck (NYSE: MRK)
    This drug company is currently yielding 3.3% and is trading lower by over 6% in the last year. A low payout ratio of 47 combined with debt to the total capital ratio of just over 36% means Merck should be able to continue paying stable dividends into the future.

  • [By Joseph Griffin]

    Gratus Capital LLC lifted its holdings in Merck & Co., Inc. (NYSE:MRK) by 108.7% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,678 shares of the company’s stock after acquiring an additional 3,999 shares during the quarter. Gratus Capital LLC’s holdings in Merck & Co., Inc. were worth $418,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    Cfra set a €89.00 ($103.49) price objective on Merck KGaA (FRA:MRK) in a research report sent to investors on Friday. The brokerage currently has a neutral rating on the healthcare company’s stock.

Leave a Reply

Your email address will not be published. Required fields are marked *